American CryoStem CEO and leadership

Mr. Arnone has been the CEO of Personal Cell Sciences since 2011 and also currently serves as the Chairman & CEO of American CryoStem. Prior to his involvement in the life sciences / biotechnology industries he spent 25 years in the investment banking/financial services industry as an investment banker, and a hands-on investor. Over a 25 year period holding 6 NASD licenses, Mr. Arnone founded, managed and operated two general securities broker-dealers based in New York specializing in strategic planning, corporate structure, financial planning and new business development. Over the years Mr. Arnone has provided advisory and business management services as a founder, officer, director and/or shareholder to both mid-level and development stage private and public companies. Mr. Arnone also co-founded and operated a global entertainment distribution corporation with 120 employees that under Mr. Arnone’s guidance was voted medium wholesaler of the year in the music industry (1997, 1998 and 2000) by the National Association of Recording Merchants. Mr. Arnone holds a degree in Business Administration and a BA. in Economics from Kean University in New Jersey.

Mr. Dudzinski has been in the life sciences and biotechnology sector for more than 8 years and has more than 25 years of experience in areas of senior management with a variety of public and private companies. Beginning in the securities industry with a focus on regulatory compliance and operations, Mr. Dudzinski combined this experience with the biotechnology industry while building new investment vehicles focused on life sciences and biotechnology companies in 2004. Mr. Dudzinski is a founder of American CryoStem Corporation and is primarily focused on building and maintaining the Company’s operational and laboratory infrastructure and their compliance with current regulations.

Michael Moeller is a Chief Scientific Officer at AMERICAN CRYOSTEM CORP. He attended University of North Texas.

Dr. Moscatello earned his B.S. in Microbiology from The Pennsylvania State University in 1975, and a Ph.D. in Biology, with a focus on cancer cell biology, from Purdue University in 1984. He has held teaching positions at Purdue University, then at Richard Stockton College of New Jersey. He returned to research as a NIH Post-doctoral fellow at the Kimmel Cancer Institute at Thomas Jefferson University working in the laboratory of Dr. Albert Wong. Dr Moscatello later accepted a position at Coriell Institute in October 1999 to pursue his own research interests Dr. Moscatello is a member of the American Association for the Advancement of Science, the American Association for Cancer Research and the American Society for Cell Biology. His primary research interests involve the isolation, culture, and characterization of adult tissue-derived stem cells, i.e., stem and multipotent progenitor cells other than embryonic stem cells. Dr. Moscatello has had articles published in a variety of media, including Nature, Journal of Biological Chemistry, International Journal of Cancer, British Journal of Cancer and Cancer Research. Dr. Moscatello will advise the Company regarding its laboratory operations and processing.

Mr. Dudzinski has been in the life sciences and biotechnology sector for more than 8 years and has more than 25 years of experience in areas of senior management with a variety of public and private companies. Beginning in the securities industry with a focus on regulatory compliance and operations, Mr. Dudzinski combined this experience with the biotechnology industry while building new investment vehicles focused on life sciences and biotechnology companies in 2004. Mr. Dudzinski is a founder of American CryoStem Corporation and is primarily focused on building and maintaining the Company’s operational and laboratory infrastructure and their compliance with current regulations.

Mr. Arnone has been the CEO of Personal Cell Sciences since 2011 and also currently serves as the Chairman & CEO of American CryoStem. Prior to his involvement in the life sciences / biotechnology industries he spent 25 years in the investment banking/financial services industry as an investment banker, and a hands-on investor. Over a 25 year period holding 6 NASD licenses, Mr. Arnone founded, managed and operated two general securities broker-dealers based in New York specializing in strategic planning, corporate structure, financial planning and new business development. Over the years Mr. Arnone has provided advisory and business management services as a founder, officer, director and/or shareholder to both mid-level and development stage private and public companies. Mr. Arnone also co-founded and operated a global entertainment distribution corporation with 120 employees that under Mr. Arnone’s guidance was voted medium wholesaler of the year in the music industry (1997, 1998 and 2000) by the National Association of Recording Merchants. Mr. Arnone holds a degree in Business Administration and a BA. in Economics from Kean University in New Jersey.

Mr. Dudzinski has been in the life sciences and biotechnology sector for more than 8 years and has more than 25 years of experience in areas of senior management with a variety of public and private companies. Beginning in the securities industry with a focus on regulatory compliance and operations, Mr. Dudzinski combined this experience with the biotechnology industry while building new investment vehicles focused on life sciences and biotechnology companies in 2004. Mr. Dudzinski is a founder of American CryoStem Corporation and is primarily focused on building and maintaining the Company’s operational and laboratory infrastructure and their compliance with current regulations.